Molecular markers of gliomas: a clinical approach.

about

Oncogene addiction in gliomas: implications for molecular targeted therapy Quantitative digital assessment of MGMT immunohistochemical expression in glioblastoma tissue.

P2860

Q35041529-20586EC9-7D24-43D5-B5C2-060796DD67E8 Q39967271-E9B10A2F-F89F-49F3-AB70-20A8463E1028

P2860

Molecular markers of gliomas: a clinical approach.

Item

http://www.wikidata.org/entity/Q36523374

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Molecular markers of gliomas: a clinical approach.

@ast

Molecular markers of gliomas: a clinical approach.

@en

type

Item

label

Molecular markers of gliomas: a clinical approach.

@ast

Molecular markers of gliomas: a clinical approach.

@en

prefLabel

Molecular markers of gliomas: a clinical approach.

@ast

Molecular markers of gliomas: a clinical approach.

@en

P1476

Molecular markers of gliomas: a clinical approach

@en

P2093

Bianchessi D

http://www.w3.org/2001/XMLSchema#string

Boiardi A

http://www.w3.org/2001/XMLSchema#string

Broggi G

http://www.w3.org/2001/XMLSchema#string

Finocchiaro G

http://www.w3.org/2001/XMLSchema#string

Menghi F

http://www.w3.org/2001/XMLSchema#string

Pollo B

http://www.w3.org/2001/XMLSchema#string

Valletta L

http://www.w3.org/2001/XMLSchema#string

P2860

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Epidemiology and etiology of gliomas.

Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.

Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas.

Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression.

Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results.

Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas.

Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survival.

Imaging correlates of molecular signatures in oligodendrogliomas.

P304

538-541

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1179/016164106X116827

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maria Grazia Bruzzone

A Silvani

M Eoli

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16808886

http://www.w3.org/2001/XMLSchema#string

Molecular markers of gliomas: a clinical approach.

about

P2860

P2860

Molecular markers of gliomas: a clinical approach.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698